Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-01

Clinical Trial Update: Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis Receiving DROGLICAN [Phase 4]

View source ↗

Summary

This document reports an update on a Phase 4 clinical study evaluating imaging markers of cartilage degradation in knee osteoarthritis patients treated with DRO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DROGLICAN

Snippet

Sponsor: Bioiberica | Conditions: Osteoarthritis, Knee | Phase 4 | Status: UNKNOWN